Article
Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study.
The pharmacogenomics journal - 1 Oct 2021
Fjukstad Katrine K, Athanasiu Lavinia, Bahrami Shahram, O'Connell Kevin S, van der Meer Dennis, Bettella Francesco, Dieset Ingrid, Steen Nils Eiel, Djurovic Srdjan, Spigset Olav, Andreassen Ole A
Abstract excerpt
Selective serotonin reuptake inhibitors (SSRIs) are prescribed both to patients with schizophrenia and bipolar disorder. Previous studies have shown associations between SSRI treatment and cardiometabolic alterations. The aim of the present study was to investigate genetic variants associated with cardiometabolic adverse effects in patients treated with SSRIs in a naturalistic setting, using a genome-wide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
